BTS Secures Top American Music Awards Honor for Second Consecutive Year US Productivity Growth Cools in Q4 as Labor Costs Rise Stirring Inflation Concerns Ethereum Treasury Firms See Staking Revenue Surge to 60 of Total Income US and China Trade Rifts Persist After TrumpXi Summit APEC Signals Show Myanmars Political Transition Requires Press Freedom Benchmarks CPJ Urges SpaceXs Starship V3 Debuts in Milestone Test Flight Carrying Mock Satellites DBGI Q3 2023 Earnings Significant Loss Per Share Amid Stock Decline RILYK Q1 2024 Earnings Net Loss Deepens Senior Notes Edge Higher PIII Q1 2026 Earnings Massive EPS Beat Drives Surprise Profitability Yet Stock Declines MillerKnoll Q1 2026 Earnings EPS Misses Estimates Amid Softening Demand Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues FrontView REIT FVR Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency Hennessy Capital Investment Corp VII Rights HVIIR Gains 3 as Support Holds Near 035 Montauk Renewables MNTK Gains 42 as Renewable Energy Stock Finds Support Near 153 British American Tobacco BTI Declines 14 as Key Support Levels Loom Luda Technology Group LUD Declines 818 as Shares Test Key Support Levels United Bankshares UBSI Edges Higher as Support Holds Steady Daiwa Upgrades Bloom Energy to Outperform Amid Clean Energy Momentum NVR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Global Interactive Technologies GITS Slips 289 as Support Level Comes into Focus RITM Q1 2026 Earnings Modest EPS Beat Highlights Stability in Mortgage Real Estate FBRX Q1 2026 Earnings PreRevenue Biotech Reports Narrow EPS Miss Amid Ongoing Development Aktis Oncology AKTS Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline Ouster Q1 2026 Earnings EPS Beats Estimates Amid Unclear Revenue Picture OCS Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investments RGA Q1 2026 Earnings Strong EPS Beat Driven by Favorable Underwriting Results RNXT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline